Congressional hearings on drug prices didn't dent drug company share prices, but the industry still faces plenty of peril, as do middlemen.
Big Pharma Survives Hearings, but Watch Out
Comment
Show comments
Hide Comments
Congressional hearings on drug prices didn't dent drug company share prices, but the industry still faces plenty of peril, as do middlemen.
